15.38
前日終値:
$15.45
開ける:
$15.34
24時間の取引高:
14.13M
Relative Volume:
1.18
時価総額:
$17.64B
収益:
$16.54B
当期純損益:
$-1.64B
株価収益率:
-10.61
EPS:
-1.45
ネットキャッシュフロー:
$749.00M
1週間 パフォーマンス:
-7.01%
1か月 パフォーマンス:
-7.57%
6か月 パフォーマンス:
-13.25%
1年 パフォーマンス:
-12.31%
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Company Profile
名前
Teva Pharmaceutical Industries Ltd Adr
セクター
電話
972 (3) 914-8213
住所
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEL AVIV
TEVA を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.38 | 17.72B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
ZTS
Zoetis Inc
|
147.38 | 64.91B | 9.29B | 2.52B | 2.28B | 5.57 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.16 | 43.33B | 29.98B | 958.27M | 5.31B | 0.2964 |
![]()
HLN
Haleon Plc Adr
|
9.66 | 42.36B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
UTHR
United Therapeutics Corp
|
294.28 | 12.42B | 2.99B | 1.21B | 1.13B | 25.06 |
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-06-06 | 開始されました | Goldman | Buy |
2025-05-28 | 開始されました | Truist | Buy |
2025-05-12 | アップグレード | JP Morgan | Neutral → Overweight |
2024-07-10 | アップグレード | Argus | Hold → Buy |
2024-03-08 | アップグレード | JP Morgan | Underweight → Neutral |
2024-02-12 | アップグレード | Piper Sandler | Neutral → Overweight |
2024-01-23 | アップグレード | Jefferies | Hold → Buy |
2024-01-03 | アップグレード | Piper Sandler | Underweight → Neutral |
2023-12-18 | 開始されました | HSBC Securities | Buy |
2023-11-27 | アップグレード | UBS | Neutral → Buy |
2023-07-06 | アップグレード | UBS | Sell → Neutral |
2023-05-25 | 開始されました | Morgan Stanley | Equal-Weight |
2023-05-18 | アップグレード | Evercore ISI | In-line → Outperform |
2023-01-19 | ダウングレード | Jefferies | Buy → Hold |
2022-11-14 | ダウングレード | JP Morgan | Neutral → Underweight |
2022-11-04 | ダウングレード | UBS | Neutral → Sell |
2022-10-21 | 再開されました | Jefferies | Buy |
2022-08-05 | アップグレード | BofA Securities | Neutral → Buy |
2022-06-14 | 再開されました | UBS | Neutral |
2022-05-17 | アップグレード | BofA Securities | Underperform → Neutral |
2022-05-04 | ダウングレード | Piper Sandler | Neutral → Underweight |
2022-04-05 | アップグレード | Barclays | Equal Weight → Overweight |
2022-03-25 | アップグレード | Bernstein | Mkt Perform → Outperform |
2022-01-27 | ダウングレード | Argus | Buy → Hold |
2021-10-28 | ダウングレード | Raymond James | Outperform → Mkt Perform |
2021-05-04 | ダウングレード | UBS | Buy → Neutral |
2021-04-07 | 再開されました | RBC Capital Mkts | Sector Perform |
2020-11-25 | 開始されました | Oppenheimer | Perform |
2020-08-06 | アップグレード | Barclays | Underweight → Equal Weight |
2020-07-27 | 再開されました | Goldman | Neutral |
2020-06-01 | アップグレード | SunTrust | Hold → Buy |
2020-04-24 | 再開されました | Citigroup | Neutral |
2020-04-06 | アップグレード | UBS | Neutral → Buy |
2020-02-24 | ダウングレード | Edward Jones | Hold → Sell |
2019-11-12 | アップグレード | JP Morgan | Underweight → Neutral |
2019-10-17 | アップグレード | Gabelli & Co | Hold → Buy |
2019-08-07 | ダウングレード | Evercore ISI | Outperform → In-line |
2019-07-19 | 開始されました | Wolfe Research | Peer Perform |
2019-07-15 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
2019-07-10 | 再開されました | Credit Suisse | Neutral |
2019-07-05 | アップグレード | Argus | Hold → Buy |
2019-06-11 | 開始されました | Barclays | Underweight |
2019-06-03 | アップグレード | Oppenheimer | Perform → Outperform |
2019-05-30 | ダウングレード | BofA/Merrill | Buy → Underperform |
2019-05-28 | ダウングレード | UBS | Buy → Neutral |
2019-03-20 | 開始されました | SunTrust | Hold |
2019-03-07 | 再開されました | UBS | Buy |
すべてを表示
Teva Pharmaceutical Industries Ltd Adr (TEVA) 最新ニュース
Teva's Pivot to Growth Strategy Underway as Innovative Portfolio Impresses and Pipeline Looks Solid - Morningstar
Teva's Innovative Portfolio Fuels 10th Consecutive Quarter of Growth in Q2 2025; Increases 2025 Revenue Outlook for Key Innovative Products and EPS, and Reaffirms All Other Components - Ariva
Head-To-Head Contrast: Teva Pharmaceutical Industries (NYSE:TEVA) & Taysha Gene Therapies (NASDAQ:TSHA) - Defense World
Billionaire Stanley Druckenmiller Sold His Entire Stake in Palantir and Has Loaded Up on These 2 Exceptional Stocks for 3 Consecutive Quarters - The Motley Fool
Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Drops -2.31%, Turning Investors Away - Stocksregister
The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough?26.06.25News - Ariva
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) Shares Bought by Yousif Capital Management LLC - Defense World
Can Teva- Pharmaceutical Industries Ltd. ADR Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com
Stocks Generating Improved Relative Strength: Teva Pharmaceutical ADR - MSN
Teva: New Long-Term Targets and Sold Pipeline Reaffirm Our Favorable Outlook; Shares Undervalued - Morningstar
Teva: New Long-Term Targets and Solid Pipeline Reaffirm Our Favorable Outlook; Shares Undervalued - Morningstar
TEVA Begins IND-Enabling Studies on Inflammatory Disease Candidate - Yahoo Finance
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Restart of Student Loan Repayments Could Squeeze Consumer Spending and Slow Economic Growth - iHeart
Bio/Pharmaceutical Outsourcing Report, March 2025 Edition - GlobeNewswire Inc.
Teva Earnings: Innovation Propels Sales and Generics Show Stability in Solid Start to the Year - Morningstar
Teva and Alvotech stocks jump on FDA approval of SELARSDI - Investing.com
Teva and Alvotech stocks jump on FDA approval of SELARSDI By Investing.com - Investing.com Canada
There Are Mixed Signals on the Chart for Teva- Pharmaceutical Industries Ltd. ADR (TEVA) - uspostnews.com
Digi Power X Inc (DGXX)’s highs and lows: A closer look at its stock price fluctuations - uspostnews.com
Market Analysts see Norwegian Cruise Line Holdings Ltd [NCLH] gaining to $21. Time to buy? - dbtnews.com
PG&E Corp [PCG] Revenue clocked in at $24.54 billion, down -14.37% YTD: What’s Next? - dbtnews.com
Greenwave Technology Solutions Inc [GWAV] Is Currently 12.13 above its 200 Period Moving Avg: What Does This Mean? – The DBT News - dbtnews.com
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Performance and Fundamentals Dashboard tells a completely different story – Sete News - Sete News
Raymond James slashes price target on Adma Biologics Inc [ADMA] – find out why. - dbtnews.com
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Stock: A Year of Highs and Lows - investchronicle.com
Company’s Banking Stock: Dissecting a 37.52% Quarterly Revenue Decline Amid Growth - investchronicle.com
NEOV’s Market Whiplash: -48.46% YTD Decline, 15.24% Rise in 30 Days - investchronicle.com
Adagio Medical Holdings Inc (ADGM) Stock: Uncovering a 52-Week Range and Trading Volume - investchronicle.com
A company insider recently sold 70,961 shares of Teva- Pharmaceutical Industries Ltd. ADR [TEVA]. Should You Sale? - knoxdaily.com
Introducing Our Rant Against Teva- Pharmaceutical Industries Ltd. ADR - uspostnews.com
OS overperforms with a 2.12 increase in share price - uspostnews.com
For Kopin Corp [KOPN], Analyst sees a rise to $2. What next? - dbtnews.com
Market Analysts see Geron Corp [GERN] falling to $2. Time to buy? - dbtnews.com
Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Is Currently 5.18 below its 200 Period Moving Avg: What Does This Mean? – The DBT News - dbtnews.com
The growth track for Teva- Pharmaceutical Industries Ltd. ADR (TEVA) has changed recently - Sete News
Rezolute Inc: Weathering Stock Market Storms with 190.08M Market Cap - investchronicle.com
Ready to Jump After Recent Trade: NIO Inc ADR (NIO) - Sete News
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Stock: Exploring a Year of Highs, Lows, and Trading Volume - investchronicle.com
ORCL’s Stock Journey: What Investors Need to Know About Oracle Corp’s Performance - investchronicle.com
TGB Stock Update: Taseko Mines Ltd’s Banking’s Market Struggles and Potential Opportunities - investchronicle.com
Lexicon Pharmaceuticals Inc (LXRX) Stock: A Year of Market Fluctuations - investchronicle.com
HESM’s latest rating updates from top analysts. - knoxdaily.com
Analysts review Teva- Pharmaceutical Industries Ltd. ADR’s rating - knoxdaily.com
Zacks Industry Outlook Dr. Reddy's, Sandoz And Teva Pharmaceuticals - Barchart.com
Zacks Industry Outlook Dr. Reddy's, Sandoz and Teva Pharmaceuticals - Yahoo Finance
3 Generic Drug Stocks to Watch Amid Trade War Jitters & Inflation Woes - Yahoo Finance
Teva Pharmaceutical Industries Ltd Adr (TEVA) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):